isogenica

About the Company: Founded over 25 years ago and based in Saffron Walden, Isogenica is a biotechnology contract research organization (CRO) specializing in the discovery and engineering of small-format, single-domain antibodies (VHH). These antibodies offer exceptional robustness, flexibility, and scalability across various therapeutic and diagnostic applications.

Services and Products: Isogenica focuses on VHH single-domain antibodies, which are derived from camelids and are now recognized as a next-generation antibody therapeutic format. The company combines the largest and most diverse synthetic VHH libraries with proprietary, cell-free CIS display technology. This approach allows Isogenica to deliver high-quality antibody solutions in about half the time of traditional immunization methods. Their services include tailored antibody discovery projects, providing industry-disrupting solutions for partners in the biopharma sector

Mission and Values: Isogenica’s mission is to advance the field of antibody research by delivering precise, high-quality results for their clients. The company values innovation, collaboration, and scientific excellence, aiming to push the boundaries of antibody discovery and engineering.

Key Strengths:

• Innovation: Isogenica leverages advanced technology and extensive synthetic VHH libraries to provide cutting-edge antibody solutions.
• Expertise: The team consists of experts from diverse backgrounds in CRO, biopharma, and academia, ensuring comprehensive and innovative approaches to antibody discovery.
• Efficiency: Their proprietary technology enables faster delivery of antibody solutions compared to traditional methods.
• Quality: Isogenica is committed to delivering high-quality, reliable results that support the development of groundbreaking therapies.

Isogenica continues to lead the way in antibody discovery and engineering, offering innovative solutions that drive advancements in therapeutic and diagnostic applications.

Visit isogenica